Lanzhou Foci Pharmaceutical Co Ltd
SZSE:002644

Watchlist Manager
Lanzhou Foci Pharmaceutical Co Ltd Logo
Lanzhou Foci Pharmaceutical Co Ltd
SZSE:002644
Watchlist
Price: 9.04 CNY 0.56% Market Closed
Market Cap: ¥4.6B

Wall Street
Price Targets

Price Targets Summary
Lanzhou Foci Pharmaceutical Co Ltd

There are no price targets for Lanzhou Foci Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Lanzhou Foci Pharmaceutical Co Ltd Competitors:
Price Targets
FCBC
First Community Bankshares Inc
9% Upside

Revenue
Forecast

10% / Year
Past Growth
-11% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
10% / Year
Past Growth
-11% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 13 years the compound annual growth rate for Lanzhou Foci Pharmaceutical Co Ltd's revenue is 10%. The projected CAGR for the next 7 years is -11%.

Operating Income
Forecast

5% / Year
Past Growth
-6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
5% / Year
Past Growth
-6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Lanzhou Foci Pharmaceutical Co Ltd's operating income is 5%. The projected CAGR for the next 9 years is -6%.

Net Income
Forecast

5% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
5% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

For the last 13 years the compound annual growth rate for Lanzhou Foci Pharmaceutical Co Ltd's net income is 5%. The projected CAGR for the next 7 years is 3%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Lanzhou Foci Pharmaceutical Co Ltd's stock price target?
Not Available

Lanzhou Foci Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Lanzhou Foci Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-11%

For the last 13 years the compound annual growth rate for Lanzhou Foci Pharmaceutical Co Ltd's revenue is 10%. The projected CAGR for the next 7 years is -11%.

What is Lanzhou Foci Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-6%

For the last 13 years the compound annual growth rate for Lanzhou Foci Pharmaceutical Co Ltd's operating income is 5%. The projected CAGR for the next 9 years is -6%.

What is Lanzhou Foci Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
3%

For the last 13 years the compound annual growth rate for Lanzhou Foci Pharmaceutical Co Ltd's net income is 5%. The projected CAGR for the next 7 years is 3%.

Back to Top